Results for tag: "Gastric Motility Disorder Drug"

The Gastric Motility Disorder Drug market is a subset of the Gastrointestinal Drugs market. It includes drugs used to treat gastric motility disorders, such as gastroparesis, functional dyspepsia, and gastroesophageal reflux disease. These drugs are used to reduce symptoms such as nausea, vomiting, abdominal pain, and bloating. Commonly used drugs include prokinetics, antacids, and proton pump inhibitors. These drugs are available in both prescription and over-the-counter forms. The Gastric Motility Disorder Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AstraZeneca, GlaxoSmithKline, Pfizer, Novartis, and Takeda. Other companies include AbbVie, Allergan, Merck, and Sanofi. Show Less Read more